Physician profile
Dayna Dunn
NPI 1639487655
$2,103.16
in general payments reported to CMS, 2019-2025
20 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $201 · 2022: $1,045 · 2023: $323 · 2024: $367 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $857.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventric Diagnostics, INC. | $595.92 | 2022 | |
| Amgen INC. | $307.69 | 2021-2025 | Repatha, Repatha |
| Irhythm Technologies, INC. | $213.86 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Janssen Pharmaceuticals, INC | $202.88 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $191.92 | 2021-2025 | |
| Heartflow, INC. | $102.58 | 2024 | |
| Merck Sharp & Dohme LLC | $75.02 | 2022-2025 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $63.51 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.55 | 2022-2025 | Jardiance |
| Abbott Laboratories | $39.51 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.13 | 2023-2024 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $34.79 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $33.29 | 2024-2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $29.84 | 2022-2024 | Farxiga |
| Pfizer INC. | $25.25 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $23.42 | 2023 | |
| Atricure, INC. | $21.99 | 2024 | |
| Novo Nordisk INC | $20.34 | 2021 | |
| Cvrx, INC. | $13.94 | 2023 | Barostim Neo System |
| Boston Scientific Corporation | $13.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dayna Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.